Highlights
Highlights
❰❱
Actualités
Generics Manufacturer Zentiva Starts Operations as Independent Company
Prague (ots/PRNewswire) - Today marks generics manufacturer Zentiva's first day as an independent organization, following completion of the company's previously announced divestment from Sanofi. Zentiva is headquartered in Prague, and the company - now backed by Advent International, one of the world's largest and most experienced global private equity investors - is ...
plusSaba Software Announces Agreement to Acquire Lumesse, Accelerating Its Global Leadership in Talent Development
Dublin, California and Luton, England (ots/PRNewswire) - Market leaders join forces to create a talent development powerhouse; offer unrivaled breadth, depth and scale to customers worldwide Saba Software Inc., a global leader in talent development solutions, and a portfolio company of Vector Capital, today ...
plusAction instead of reaction: KfW supports innovative drought insurance for emergency aid organisations in Africa
Frankfurt am Main (ots) - - EUR 10 million for ARC Replica, the new approach by African Risk Capacity drought insurance - Insurance agreements concluded with the World Food Programme and START Network - More emergency aid measures and faster effective aid possible On behalf of the German Federal Ministry for ...
plusKyowa Kirin Presents Data at EORTC-Cutaneous Lymphoma Task Force Meeting Showing Significantly Improved Quality of Life for Patients With Mycosis Fungoides (MF) and Sézary Syndrome (SS) on Mogamulizumab
Tokyo (ots/PRNewswire) - First oral presentation of Quality of Life data from the phase III trial (MAVORIC), the largest randomised trial in MF and SS - the two most common types of Cutaneous T Cell Lymphoma[1] Kyowa Hakko Kirin Co., Ltd., (Kyowa Kirin) announces that Quality of Life (QoL) data from the pivotal ...
plusInternational Diabetes Federation (IDF) Global Survey Reveals 2 in 3 People With Type 2 Diabetes Have Cardiovascular Disease Risk Factors and/or Have Experienced a Cardiovascular Event
Bagsværd, Denmark (ots/PRNewswire) - - Cardiovascular disease (CVD) is the leading cause of disability and death in people with type 2 diabetes[1] - Despite the high incidence, 1 in 4 people with type 2 diabetes have never discussed, or cannot recall discussing, CVD risk factors with a doctor[2] - First-ever global ...
plusVifor Pharma Wins 2018 Pharma 4.0 Award for Implementation of Augmented Reality System
Zurich (ots/PRNewswire) - Vifor Pharma Group today announced that the company and partner Goodly Innovations were awarded the 2018 Pharma 4.0 Award for the innovation of the year in manufacturing execution systems in the pharma industry. Presented on 24 September in Berlin, the purpose of the Pharma 4.0 Award is to recognise outstanding implementation in manufacturing ...
plus
New Phase 2 Data for Somapacitan Demonstrate Its Potential as an Efficacious Once-weekly Treatment for Childhood Growth Hormone Deficiency
Athens, Greece (ots/PRNewswire) - Somapacitan, a novel growth hormone derivative in development for once-weekly administration of growth hormone, matched the therapeutic benefits of once-daily Norditropin® (somatropin) in a phase 2 trial in children with growth hormone deficiency.[1] There are currently no approved ...
plusVolvo Trucks to Introduce All-electric Trucks in North America
Greensboro, North Carolina and Gothenburg, Sweden (ots/PRNewswire) - As part of an innovative partnership between the Volvo Group, California's South Coast Air Quality Management District (SCAQMD), and industry leaders in transportation and electrical charging infrastructure, Volvo Trucks will introduce all-electric truck demonstrators in California next year, and ...
plusTravelsify Raises EUR5 Million in New Funding Round and Launches Brand DNA AI Analytics for Hotels and Restaurants
New York and Luxembourg (ots/PRNewswire) - New Funding Round, Led By AccorHotels, To Accelerate The Development Of Services Leveraging Travelsify's Hotel DNA(TM) and Restaurant DNA(TM) AI Technology Travelsify (http://www.travelsify.com/), the world's first Travel & Lifestyle Product DNA platform, today announced ...
plusSuccessful Launch of Merieux Participations 3, The New Growth Capital Fund of Merieux Equity Partners
Lyon, France (ots/PRNewswire) - Mérieux Equity Partners, a management company created by Mérieux Développement, announces the first closing of its third generation fund, Mérieux Participations 3, focusing on growth capital within the healthcare and nutrition sectors. (Logo: ...
plusMakor Group Announces the Expansion of Its Team and Scope of Activities in Switzerland
Geneva (ots/PRNewswire) - Makor Capital Markets S.A, the Geneva-based representative office of leading independent Equity, Fixed Income and FX Research and Brokerage firm Makor Securities continues to expand the scope of its activities in Switzerland. Makor Capital Markets has hired Sebastien Crouzet to build the Cross-Asset Services Desk. Prior to joining Makor, ...
plusEANS-Adhoc: Lenzing / Lenzing temporarily mothballs lyocell expansion project in Mobile, Alabama
issuer: Lenzing AG A-A-4860 Lenzing phone: +43 7672-701-0 FAX: +43 7672-96301 mail: office@lenzing.com WWW: http://www.lenzing.com ISIN: AT0000644505 indexes: ATX, WBI stockmarkets: Wien language: English ...
plus
India hosts the Mahatma Gandhi International Sanitation Convention / 29th September to 2nd October 2018, New Delhi
New Delhi (ots) - Ministers and sanitation sector leaders from around the world will convene this month at the Mahatma Gandhi International Sanitation Convention (MGISC) in New Delhi. Hosted by the Government of India, this event will be an opportunity for delegates to exchange sanitation successes and best ...
plusKenshoo Announces Support of Apple Search Ads
San Francisco (ots/PRNewswire) - Kenshoo's new relationship enables marketers to capitalize on Apple Search Ads' continued growth and entrance into more markets at scale Kenshoo (http://www.kenshoo.com) (http://www.Kenshoo.com), a global leader in marketing technology, today announced it has become an Apple Search Ads Authorized Reseller, adding support for Apple Search Ads to the Kenshoo Marketing Platform. Apple Search ...
plusMeMed Raises Over $70 Million to Advance Pioneering Point-Of-Care Platform and Immune-Based Test for Distinguishing Bacterial Versus Viral Infections
Haifa, Israel (ots/PRNewswire) - Round includes leading international investors, further solidifying MeMed's leadership in host-based diagnostics MeMed today announced the completion of a new round of financing totaling over $70 million, with participation from new and existing investors including Ping An Global ...
plusFuture Health Index, Commissioned by Philips, Identifies Key Recommendations for Better Health Information Exchange to Drive Value in Healthcare
Amsterdam (ots/PRNewswire) - Royal Philips (http://www.philips.com/) (NYSE: PHG) (AEX: PHIA), a global leader in health technology, today released a new Future Health Index (FHI) report "Moving data to the heart of health systems: Increasing vital technology adoption to make value-based healthcare a reality ...
plusBlockEx Strongly Supports UK Treasury Committee Recommendations for Regulated Crypto Trading Market
London (ots/PRNewswire) - Market reputation will be greatly improved by regulation BlockEx, the digital asset exchange provider for institutional-grade financial markets, has announced that it strongly supports the Treasury Committee recommendations for a regulated UK crypto-asset trading market. (Logo: ...
plusGoodyear Eagle F1 Asymmetric 3 SUV Fitted on Audi e-tron in San Francisco
Brussels (ots/PRNewswire) - Goodyear ultra-high performing tires are chosen for Audi's first ever electric SUV Audi revealed its e-tron today, which is the first fully electric SUV to be commercialized by the German car manufacturer. Goodyear has supplied this groundbreaking model with its Eagle F1 Asymmetric 3 SUV tires in 265/45R21 SUV size. (Photo: ...
plus
Schweizerischer Nationalfonds / Fonds national suisse
Marie Heim-Vögtlin Prize 2018: Sara Montagner discovers the epigenetic secrets of mast cells
Bern (ots) - Epigenetic modifications of our DNA are a key aspect of the normal functioning of mast cells, which play an important role in immune reactions. Biologist Sara Montagner was able to demonstrate this in her work. She will receive this year's Marie Heim-Vögtlin Prize from the SNSF at the award ceremony in Bellinzona on 29 November 2018. Mast cells are white ...
plusThe Globe and Mail Launches Canada's First Premium Subscription Cannabis News Service
Toronto (ots/PRNewswire) - Report on Business Cannabis Professional supported by dedicated journalism team With unprecedented resources and the largest dedicated cannabis coverage team in the market, The Globe and Mail today launched Report on Business Cannabis Professional, a premium subscription news service for global cannabis insiders and investors. Backed by The ...
plusNOS Enhances User Experience With Concurrent's MediaScaleX Platform
Duluth, Georgia (ots/PRNewswire) - Concurrent Technology Inc., a Vecima Company (TSX: VCM), and NOS have announced an expanded partnership, enabling NOS to continue its leadership in delivering cutting edge media and entertainment offerings to all of Portugal. As part of the agreement, NOS will deploy Concurrent's MediaScaleX(TM) platform, enhancing user experiences for Cloud DVR and Live TV delivered via IP. MediaScaleX ...
plusConcurrent Containerized Solutions Powering Qvest.Cloud
Duluth, Georgia (ots/PRNewswire) - Concurrent Technology Inc., a Vecima Company (TSX: VCM), the global leader in media delivery and storage solutions for content owners, broadcasters and service providers, and Qvest Media, one of the world's leading systems architects and ICT integrators for broadcast and media technology, today announced that they have signed a global reseller agreement and that Concurrent's ...
plusConcurrent Technology Unveils MediaScaleX at IBC2018
Duluth, Georgia (ots/PRNewswire) - New brand and breakthrough innovation unites existing media delivery and storage solutions as a single content delivery platform Concurrent Technology Inc. (https://www.concurrent.com/), a Vecima Company (TSX: VCM), the global leader in media delivery and storage solutions for content owners, broadcasters and service providers, announces the launch of MediaScaleX(TM), a next-generation ...
plusCargill's European Poultry Business Expands Into Poland With Acquisition of Konspol
London (ots/PRNewswire) - Cargill has reached an agreement to acquire Konspol, one of Poland's leading value-added food companies, providing an array of products in the chilled convenience, frozen and cold cut categories. This acquisition marks the introduction of Cargill's global protein business into the Polish market and strengthens the company's global poultry ...
plus
Qooder: opening of the first Quadro Vehicles Store in Paris
plusPhilips Unveils Trilogy Evo and Growing Portfolio of Connected Solutions at ERS 2018
Amsterdam and Paris (ots/PRNewswire) - New portable ventilator builds on Philips respiratory clinical excellence to enhance transitional care coordination and collaboration At the European Respiratory Society (ERS) International Congress 2018 in Paris, France (September 15-19), Royal Philips (http://www.usa.philips.com/) (NYSE: PHG) (AEX: PHIA), a global leader in ...
plusControlExpert continues generation change in top management / Nicolas Witte takes over from Kai Siersleben
plusEIT Digital at the Heart of Europe's Digital Innovation Priorities
Brussels (ots/PRNewswire) - With activities focused on Digital Infrastructure (data science, machine learning, cybersecurity and next generation networks), Digital Industry, Digital Wellbeing, Digital Cities and Digital Finance, the results and impact of EIT Digital are at the heart of the priorities, recently identified by the European Commission and national ...
plusBAVENCIO® (avelumab) Plus INLYTA® (axitinib) Significantly Improved Progression-Free Survival in Previously Untreated Patients With Advanced Renal Cell Carcinoma in Phase III Study
Darmstadt, Germany and New York (ots/PRNewswire) - Not intended for US, Canada and UK-based media - First positive Phase III immunotherapy trial in combination with a tyrosine kinase inhibitor (TKI) in any tumor type - Results significant in both PDL1+ and all-comer populations - Alliance plans to pursue a ...
plusSynova Launches Ultra-Precise Laser Machining Center LCS 305
plus